pharmafocusAmerica Magazine

Issue 02 | 2023

We are thrilled to announce the release of the second edition of Pharma Focus America magazine for

Antibody drug conjugates ADCs are innovative modalities to deliver chemotherapeutics to specifically targeted populations of cancer cells

The macroeconomic fundamentals of the pharmaceutical industry remain strong

Although genes encode cellular functions and fates with DNA acting as an inert cookbook metabolism is the lifeblood of every living cell

Emerging technologies are technologies that are in the early stages of adoption in drug substance and drug product development

A number of exciting innovations have begun to gain the attention of companies within the pharmaceutical sector Artificial intelligence AI

EBR systems are more reliable and compliance than traditional paper documents log in measures

Antibody humanization and affinity maturation have revolutionized the biotech industry in the past years